News

ITM and Swiss-based Debiopharm have announced the imaging of the first subject in a new study arm (Part D) of the Phase I/II ...
Johnson & Johnson (J&J) has launched a new daily disposable contact lens for individuals with astigmatism and presbyopia.
Illumina expects the addition of a high-margin revenue stream, although the deal is expected to close in 2026.
The US Food and Drug Administration (FDA) has granted 510(k) clearance to DeepEcho’s foetal ultrasound analysis platform.